Venture Life Group (LON:VLG) Share Price Passes Above 50-Day Moving Average – What’s Next?

Venture Life Group plc (LON:VLG) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 57.25 and traded as high as GBX 62. Venture Life Group shares last traded at GBX 61.50, with a volume of 271,131 shares traded.

Venture Life Group Stock Performance

The company has a fifty day moving average price of GBX 57.25 and a two-hundred day moving average price of GBX 56.89. The firm has a market cap of £81.27 million, a price-to-earnings ratio of -83.80, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a current ratio of 2.22 and a quick ratio of 1.48.

Venture Life Group (LON:VLG) last issued its quarterly earnings results on Tuesday, September 30th. The company reported GBX 0.83 EPS for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. As a group, equities research analysts expect that Venture Life Group plc will post 6.1391542 EPS for the current year.

Insider Buying and Selling

In other Venture Life Group news, insider Mark Adams bought 88,999 shares of Venture Life Group stock in a transaction that occurred on Friday, October 3rd. The stock was purchased at an average cost of GBX 56 per share, for a total transaction of £49,839.44. 6.84% of the stock is currently owned by corporate insiders.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.